help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shin, B.-C.
Right arrow Articles by Takata, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shin, B.-C.
Right arrow Articles by Takata, K.
Endocrinology Vol. 138, No. 9 3997-4004
Copyright © 1997 by The Endocrine Society


ARTICLES

Glucose Transporter GLUT3 in the Rat Placental Barrier: A Possible Machinery for the Transplacental Transfer of Glucose

Bo-Chul Shin, Keiko Fujikura, Takeshi Suzuki, Shigeyasu Tanaka and Kuniaki Takata

Laboratory of Molecular and Cellular Morphology, Department of Cell Biology, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Gunma 371, Japan

Address all correspondence and requests for reprints to: Kuniaki Takata, Ph.D., Laboratory of Molecular and Cellular Morphology, Department of Cell Biology, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Gunma 371, Japan.


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Glucose transfer across the placental barrier is crucial for fetal development. To investigate the role of glucose transporter isoforms in the transplacental transfer of glucose, we investigated the localization of glucose transporters GLUT1 and GLUT3 immunohistochemically in the rat placenta. In the labyrinth, the site of maternofetal exchange of substances, both GLUT1 and GLUT3 were present, whereas only GLUT1 was detected in the junctional region. In the labyrinthine wall, which lies between maternal and fetal circulations, GLUT3 exhibited polarized localization; i.e. it was present at the plasma membranes of the maternal blood side in the syncytiotrophoblast layers. GLUT1 was concentrated at plasma membranes of the maternal and fetal blood sides of syncytiotrophoblast layers. The asymmetric distribution of GLUT3 across the placental barrier may suggest asymmetric transfer of glucose, which would be beneficial to provide a stable milieu for fetal development.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
GLUCOSE is one of the major energy sources in the mammalian body. The cellular uptake of glucose across the plasma membrane is mediated by integral membrane proteins, glucose transporters. Two kinds of glucose transporters have been identified (1, 2, 3, 4, 5, 6): facilitated-diffusion glucose transporters for the concentration-dependent transport of glucose across the membrane, and Na+-dependent transporters for the active absorption of glucose against the concentration gradient in the intestine and kidney cells. Mammalian facilitated-diffusion glucose transporters, the GLUTs, are expressed tissue specifically (2, 3, 5, 7, 8, 9, 10). GLUT1 is concentrated at the critical plasma membranes of blood-tissue barriers (11) such as the blood-brain barrier (12), the blood-ocular barrier (13, 14, 15, 16), and the placental barrier (17, 18, 19, 20, 21). GLUT2, an isoform with low affinity and high capacity, is present in liver, intestine, kidney, and pancreatic ß-cells (22). In rodents, GLUT3 is abundant in the brain (10, 23, 24, 25, 26) and is also expressed in the placenta (10, 25, 27, 28, 29). GLUT4 is specifically expressed in fat and muscle cells, whose translocation by insulin from the intracellular pool plays a pivotal role in the maintenance of the blood glucose level (30, 31, 32, 33).

Glucose is transferred from the maternal blood to the fetal circulation across the placental barrier, which separates the maternal and fetal circulation. In contrast to the human placenta, where numerous villi are formed (34), a complex of maternal and fetal circulations termed the labyrinth, develops in the rat placenta (35). The labyrinthine part of the placenta is the principal site of maternofetal exchange of substances. The labyrinthine wall, or interhemal membrane, which lies between the maternal blood space and fetal vessels, is composed of three layers of trophoblast (36, 37), i.e. the porous cytotrophoblast layers and syncytiotrophoblast layers I and II, from the maternal to fetal sides. We have previously shown by immunoblotting that GLUT1 protein is abundant in the rat placenta (21, 38, 39). In situ hybridization also confirmed the expression of GLUT1 (28). Immunohistochemical analysis revealed that GLUT1 is present in the syncytial cell layers. Detailed examination revealed the localization of GLUT1 at the plasma membranes of the maternal blood side of syncytiotrophoblast I and the fetal blood side of syncytiotrophoblast II (39). Syncytiotrophoblasts I and II are connected by numerous gap junctions (40, 41, 42). Immunohistochemical examination showed that these gap junctions are made of connexin 26 (Cx26), an isoform of gap junction channel proteins (16). We proposed that GLUT1, connexin 26, and GLUT1 lined in series in the syncytiotrophoblast layers constitute the machinery for the transplacental transfer of glucose through the rat placental barrier (11, 19, 21).

In addition to GLUT1, GLUT3 has been shown to be expressed in the rat placenta; and its possible involvement in the maternofetal transfer of glucose was suggested (28). The precise cellular localization of GLUT3 and comparison of the localization between GLUT1, GLUT3, and connexin 26, however, has not been made in the rat placental barrier. As such information should shed light on the glucose transfer machinery in the placental barrier, in this study we raised antibodies against rat GLUT3 and examined the localization of GLUT3 protein in the rat placental barrier by double-immunofluorescence staining for GLUT1 and GLUT3. We suggest a possible mechanism involving GLUT1, GLUT3, and connexin 26 for the transplacental transfer of glucose across the rat placental barrier.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Antibodies
Anti-GLUT1 and anti-GLUT4 antibodies were raised in guinea pigs against the synthetic peptides corresponding to amino acids 480–492 (C-terminus) and 502–509 (C-terminus) of the deduced amino acid sequences of human GLUT1 (43) and rat GLUT4 (30), respectively, by use of keyhole limpet hemocyanin conjugates. Rabbit anti-GLUT1 antibodies raised against purified human erythrocyte glucose transporter (44) and against human GLUT1 C-terminus peptide (39) were also used. Anti-GLUT3 antibody was raised in a rabbit against the synthetic peptide corresponding to amino acids 449–458 (C-terminus) of the deduced amino-acid sequence of rat GLUT3 (23, 45), basically as described (46). In short, a rabbit received subcutaneous multiple immunizations followed by four iv booster injections of keyhole limpet hemocyanin-conjugated peptide antigen. Rabbit antirat GLUT2 was purchased from East Acres Biologicals (Southbridge, MA). Anti-GLUT5 antibody was raised in the rabbit and characterized as previously described (47).

Tissue preparations
Wistar rats at 12, 14, 16, and 18 days of pregnancy were obtained from Imai Experimental Animal Farm (Gunma, Japan). Days of pregnancy were designated as previously described (39). The animals were anesthetized with sodium pentobarbital, and placentas (n = 8–10 from each animal) were removed, cut into pieces, and washed with PBS to remove blood. Brain (cerebral cortex) was taken from male 4-week-old Wistar rats supplied from the Animal Breeding Facility, Gunma University (Gunma, Japan).

Immunoblotting
The tissue specimens were homogenized in PBS containing protease inhibitors (38). Protein content was measured by the BCA Protein Assay Reagent (Pierce, Rockford, IL). Homogenate (10 µg of protein) was electrophoresed through SDS polyacrylamide gels and transferred to membrane filters (Immobilon-PSQ, Millipore, Bedford, MA). The blotted membranes were sequentially incubated with 3% BSA, guinea pig anti-GLUT1 or rabbit anti-GLUT3 antibodies diluted at 1:1000 each, and 125I-protein A (New England Nuclear, Wilmington, DE). Autoradiography was performed for 0.5–18 h with imaging plates, and the plates were processed with a BAS2000 bioimage analyzer (Fuji Film, Tokyo, Japan).

Light-microscopic immunohistochemistry
Specimens were fixed in 4% formaldehyde in 0.1 M sodium phosphate buffer, pH 7.4, for 3 h at room temperature, washed with PBS, infused in 20% sucrose in 0.1 M sodium phosphate buffer, pH 7.4, containing 0.02% sodium azide, and embedded in OCT compound. Specimens were rapidly frozen in liquid nitrogen, and then sectioned (6-µm thickness) with a cryostat. Some of the fixed specimens were cut into small pieces and infused with 2.3 M sucrose in 0.1 M sodium phosphate buffer, pH 7.4, containing 0.02% sodium azide. Infused tissue blocks were mounted on stubs and rapidly frozen in liquid nitrogen. Semithin frozen sections (0.5–1 µm thickness) were cut at -60 C with a Leica Ultracut S UCT ultramicrotome equipped with an EM FCS cryokit (Leica, Austria) and glass knives and collected on glass slides. Immunofluorescence staining was carried out essentially as previously described (16, 21, 39). For double-immunofluorescence staining for GLUT1 and GLUT3, sections were covered with 5% normal goat serum in PBS for 10 min and incubated for 1 h with a mixture of guinea pig anti-GLUT1 antibody and rabbit anti-GLUT3 antibody, each diluted at 1:500 and 1:1000, respectively. After having been washed with PBS, the sections were incubated with a mixture of DTAF (dichlorotriazinyl amino fluorescein)-labeled donkey antiguinea pig IgG (Jackson Immunoresearch, West Glove, PA), LRSC (lissamine rhodamine sulfonyl chloride)-labeled donkey anti-rabbit IgG (Jackson Immunoresearch), and DAPI (4',6-diamidino-2-phenylindole dihydrochloride, Boehringer-Mannheim, Mannheim, Germany) for 1 h. Specimens were washed with PBS, mounted using antibleaching mounting medium (21), and examined with a BX-50 microscope (Olympus, Tokyo, Japan) equipped with epifluorescence and Nomarski differential interference-contrast optics.

Electron-microscopic immunohistochemistry
Specimens were fixed in 4% formaldehyde in 0.1 M sodium phosphate buffer, pH 7.4, for 3 h at room temperature, and washed with PBS. They were infused with 20% sucrose in 0.1 M sodium phosphate buffer, pH 7.4, containing 0.02% sodium azide, embedded in OCT compound (Miles, Elkhart, IN), and rapidly frozen in liquid nitrogen. Cryostat sections (10-µm thickness) were cut and mounted on glass slides coated with poly-L-lysine. The sections were covered with 5% normal goat serum in PBS for 10 min and incubated for 1 h at room temperature with rabbit anti-GLUT3 antibody diluted at 1:1000. After a rinse with PBS, sections were incubated for 1 h at room temperature with 1.4-nm gold particles conjugated to Fab' fragments of antirabbit IgG (Nanogold, Nanoprobes, Stony Brook, NY), diluted at 1:50 (48). After a rinse with PBS, the sections were refixed with 1% glutaraldehyde for 30 min. The labeled sections were next washed for 30 min with six changes of PBS and incubated with silver enhancement solution containing 1 mg/ml silver acetate, 14 mg/ml trisodium citrate dihydrate, 15 mg/ml citric acid monohydrate, and 2.5 mg/ml hydroquinone, for 3–15 min at room temperature (49). After two quick rinses with distilled water, the specimens were immersed in 0.05% sodium acetate for 1 min, and then, after a rinse for 30 min in six changes of water, were treated with 0.05% chloroauric acid for 2 min at room temperature. After another rinse for 30 min in six changes of water, the sections were fixed with 1% osmium tetroxide in 0.1 M sodium phosphate buffer, pH 7.4, for 30 min, dehydrated through a series of graded ethanols, and embedded in epoxy resin. Ultrathin sections were cut, stained with uranyl acetate and lead citrate, and examined with a JEM-1010 transmission electron microscope (JEOL, Tokyo, Japan).

Immunohistochemical controls
Sections were incubated with normal serum instead of the primary antibody. The specificity was also checked by incubation with the primary antibody in the presence of the peptides (5 µg/ml) used to generate the antibody. These immunohistochemical controls were carried out side by side with the experimental slides for both immunofluorescence and immunoelectron microscopic immunohistochemistry.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Immunoblotting
By using the rabbit antirat GLUT3 antibody, we detected a 45-kDa protein in rat brain cerebral cortex homogenate (Fig. 1aGo). In the 18-day placenta homogenate, a 40-kDa protein was detected, showing the presence of the GLUT3 glucose transporter in the rat placenta (Fig. 1bGo). A 42-kDa protein was detected in the homogenate of the 18-day placenta with the guinea pig anti-GLUT1 (Fig. 1cGo), which confirmed our previous results (21).



View larger version (35K):
[in this window]
[in a new window]
 
Figure 1. Immunoblotting analysis of the rat placenta with antibodies against GLUT1 and GLUT3. Brain and 18-day placenta homogenates (10 µg protein each) were subjected to SDS-PAGE. The brain specimen was immunoblotted with rabbit anti-GLUT3 antibody (a), and placenta specimens with rabbit anti-GLUT3 (b) or guinea pig anti-GLUT1 antibody (c).

 
Immunofluorescence localization of GLUT3 and GLUT1
Development of the labyrinth of the rat placenta begins around day 12 (35). Although the labyrinth occupies only a small portion of the placenta at first, it becomes a major part of the placenta in day 18. Labyrinth and junctional zone were easily distinguished by nuclear DNA staining as previously described (29). In the rat placental labyrinth, the maternal blood space and fetal blood vessels were distinguished according to the criteria described previously (21, 39, 41). In short, the maternal blood space faces the large nuclei of the cytotrophoblast, whereas the fetal blood vessels are lined with smaller nuclei of endothelial cells.

Localization of GLUT3 and GLUT1 was carried out by immunofluorescence staining of cryostat (Fig. 2Go) and semithin frozen sections (Fig. 3Go) of rat placentas. We examined the localization of GLUT1 and GLUT3 on days 12, 14, 16, and 18. On day 12, both GLUT3 and GLUT1 were detected in the labyrinth, whereas only GLUT1 labeling, although weak, was detected in the junctional zone (Fig. 2Go, a–f). GLUT3 staining was restricted to the labyrinth. On day 18, both GLUT3 and GLUT1 were present in the labyrinth, where maternofetal exchange of substances occurs (Fig. 2Go, g–i). In the junctional zone, strong labeling for GLUT1 was detected (Fig. 2hGo), but no labeling for GLUT3 (Fig. 2gGo).



View larger version (156K):
[in this window]
[in a new window]
 
Figure 2. Immunofluorescence localization of GLUT3 and GLUT1 in 12-day (a–f) and 18-day (g–i) rat placentas. Cryostat sections were doubly stained for GLUT3 with LRSC-label (a, g) and for GLUT1 with DTAF-label (b, h). Corresponding Nomarski-differential interference-contrast image (i) is shown. Immunohistochemical controls in 12-day placenta (c–f) are also shown. La, Labyrinthine region; Ju, junctional region. Bar, 100 µm. a and b, In the labyrinth, both GLUT3 and GLUT1 are present, whereas only weak labeling for GLUT1 is seen in the junctional region. c–f, In the immunohistochemical controls, no positive staining is seen with either normal rabbit serum (c), or normal guinea pig serum (e). To identify labyrinthine and junctional regions, corresponding nuclear DNA images with DAPI (d, f) are shown. g–i, Localization of GLUT3 is restricted to the labyrinth as well (g), whereas GLUT1 is present in both the junctional and labyrinthine regions (h).

 


View larger version (109K):
[in this window]
[in a new window]
 
Figure 3. Immunofluorescence localization of GLUT3 and GLUT1 in the labyrinth in semithin-frozen sections. Sections were stained for GLUT3 with LRSC-label (red), and for GLUT1 with DTAF-label (green). Nuclei were counterstained with DAPI (blue). Regions of overlap of red and green fluorescence appear yellow on double exposures. Images for GLUT3 (a, d, g), and GLUT1 (b, e, h), as well as double-exposure images for both (c, f, i), are shown. Corresponding Nomarski-differential interference-contrast image (j) is also shown. M, Maternal blood space; F, fetal blood vessel; Cy, cytotrophoblast; *, undifferentiated cells. Bars, 10 µm. a–c, Labyrinth of 12-day placenta. a, GLUT3 (red) is seen as two lines between the maternal and fetal circulations (double arrowheads, arrowheads) in the labyrinth. b, GLUT1 (green) is seen as three lines (double arrowheads, arrowheads, and arrows). GLUT1 is also present in undifferentiated cells (*). c, A double-exposure image shows three distinct lines of various width: the first one (double arrowheads) along the maternal blood space, the second one (arrowheads) between syncytiotrophoblastic layers I and II, and the third one (arrows) facing the fetal blood vessel or undifferentiated cells. Note that GLUT3 and GLUT1 are colocalized in the first and second lines, whereas only GLUT1 is seen in the innermost, third line. d–f, Labyrinth of 14-day placenta. d, GLUT3 (red) is seen as two lines between maternal and fetal circulations (double arrowhead, arrowhead). e, GLUT1 (green) is also seen as two lines (double arrowhead, arrow). f, A double-exposure image shows three distinct lines similar to those in 18-day placenta (double arrowhead, arrowhead, arrow). g–i, Labyrinth of 18-day placenta. g, GLUT3 (red) is seen as two lines between maternal and fetal circulations (double arrowhead, arrowhead). h, GLUT1 (green) is also seen as two lines but with a wider space (double arrowhead, arrow). i, A double-exposure image shows three distinct lines. The first one, closest to the maternal blood, is positive for both GLUT3 and GLUT1 (double arrowhead, yellow). The middle one, lying between syncytiotrophoblast layers I and II, is positive for GLUT3 (arrowhead, red). The innermost one, next to a fetal capillary (F), is positive for GLUT1 (arrow, green). Positive staining for GLUT3 or GLUT1 was not seen in cytotrophoblast or endothelial cells of fetal blood vessels in the 12-, 14-, or 18-day placenta.

 
To further analyze the localization of GLUT1 and GLUT3 in the labyrinthine wall, we examined semithin frozen sections (Fig. 3Go). On day 12, three GLUT1-positive lines were evident in the syncytiotrophoblast layers located between the maternal blood space and fetal capillaries in the labyrinth (Fig. 3bGo). In addition to syncytiotrophoblast layers, nonsyncytial undifferentiated cells located beneath the syncytial cells were positive for GLUT1 (Fig. 3bGo). GLUT3 labeling in the syncytial cell layer formed two positive lines between the maternal blood space and fetal capillaries (Fig. 3aGo). Nonsyncytial undifferentiated cells were negative or weak for GLUT3 labeling. Double-exposure images showed three lines along syncytiotrophoblast layers: yellow, yellow, and green from the maternal side (Fig. 3cGo), showing the coexistence of GLUT3 and GLUT1 in the maternal side of syncytiotrophoblast I and between syncytiotrophoblast layers I and II. The basal side of syncytiotrophoblast II was positive for GLUT1 only (Fig. 3cGo). Neither GLUT3 nor GLUT1 was detected in cytotrophoblasts directly facing the maternal blood in the labyrinth (Fig. 3Go, a–c). Localization pattern of GLUT3 and GLUT1 in the labyrinthine wall began to change on day 14 where decrease of GLUT1 labeling in between syncytiotrophoblast layers I and II was evident (Fig. 3Go, d–f). On days 16 and 18, the labyrinth was occupied with typical placental labyrinthine structure with a single cytotrophoblast layer, two syncytial layers, and fetal endothelium. Undifferentiated trophoblasts were rarely encountered. GLUT1 exhibited two distinct lines along the double syncytiotrophoblast layers separating the maternal blood space and fetal blood vessels (Fig. 3hGo). Positive staining for GLUT1 was not seen in cytotrophoblast or endothelial cells of fetal blood vessels. GLUT3 was localized along double syncytial layers facing the maternal blood space and between the double syncytial layers, forming two distinct lines (Fig. 3gGo). Positive staining for GLUT3 was not seen in cytotrophoblast or endothelial cells of fetal blood vessels, either. Double-exposure images clearly showed that GLUT3 and GLUT1 were colocalized in syncytiotrophoblastic layer I along the cell contour facing the maternal blood space (Fig. 3iGo). Between double syncytial layers in the interhemal membrane, only GLUT3 was detected. Only GLUT1 was present along the cell contour of syncytiotrophoblast layer II facing the fetal blood vessels. Three anti-GLUT1 antibodies, two of them raised in rabbits and one in a guinea pig, gave the same staining pattern (data not shown). Other glucose transporter isoforms tested, i.e. GLUT2, GLUT4, and GLUT5, showed no positive staining in the labyrinth (data not shown).

Ultrastructural localization of GLUT3 in 18-day placenta
To examine the ultrastructural localization of GLUT3, we used Nanogold probes to carry out preembedding electron-microscopic immunohistochemistry on the 18-day placenta. In the labyrinth, GLUT3 was localized at the plasma membrane of syncytiotrophoblast I facing the maternal blood space (Fig. 4Go, a and b). It was also present at the plasma membrane of the syncytiotrophoblast II facing syncytiotrophoblast I (Fig. 4Go, c and d). The basal side of syncytiotrophoblast II and the plasma membrane of syncytiotrophoblast I facing syncytiotrophoblast II were negative for GLUT3.



View larger version (178K):
[in this window]
[in a new window]
 
Figure 4. Ultrastructural localization of GLUT3 in 18-day rat placental labyrinth by the immunogold-labeling method. M, Maternal blood space; F, fetal capillary; Cyt, cytotrophoblast; End, endothelial cell of a fetal capillary. a, A survey view of the labyrinthine wall. Positive staining for GLUT3 is seen in the membrane of syncytiotrophoblast layer I (Syn I) facing the maternal blood side (arrowheads). GLUT3 is also present in between syncytiotrophoblast layers I and II (Syn II) (arrows). Positive staining for GLUT3 is not seen in cytotrophoblast or endothelial cells of fetal blood vessels. Bar, 1 µm. b, GLUT3 is seen along the plasma membrane of syncytiotrophoblast layers I (Syn I) facing the cytotrophoblast (arrowheads). Bar, 0.5 µm. c and d, GLUT3 is localized at the plasma membrane (arrows) of syncytiotrophoblast layer II (Syn II). Bar, 0.5 µm.

 
Immunohistochemical controls
When the primary antibody was replaced with normal serum (Fig. 2Go, c–f) or a mixture of the primary antibody and 5 µg/ml antigen peptide, no positive labeling was seen in either immunofluorescence or immunogold studies (data not shown). In the double-immunofluorescence studies, replacement of one of the primary antibodies with normal serum did not affect the staining with the other antibody. These control experiments confirmed the specificity of the immunostaining.


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The rat placenta is divided into two parts, the junctional zone and the labyrinthine zone. Maternofetal exchange of substances including glucose occurs in the labyrinth. By immunoblotting and immunohistochemistry, we have demonstrated here the presence and localization of glucose transporter isoforms GLUT3 and GLUT1 in the rat placenta. The double-immunofluorescence studies clearly showed the location of GLUT1 and GLUT3 in the mature placenta: both GLUT1 and GLUT3 were present in the labyrinthine region, whereas only GLUT1 was found in the junctional region. In the labyrinth, or the interhemal membrane, we localized GLUT1 and GLUT3 precisely in syncytiotrophoblasts: colocalization of GLUT1 and GLUT3 at the plasma membrane facing the maternal blood side, GLUT1 at the membrane of syncytiotrophoblast II facing fetal blood vessels, and GLUT3 at the membrane of syncytiotrophoblast II adjacent to syncytiotrophoblast I. These findings suggest that GLUT1 and GLUT3 may serve in concert for the maternofetal transfer of glucose.

Expression of GLUT1 alone in the junctional region, but expression of both GLUT1 and GLUT3 in the labyrinthine part, was reported earlier (28, 29), and our findings (Fig. 2Go) are consistent with their results. Because GLUT1 is ubiquitous in the placenta, it was suggested that GLUT1 may be responsible for supplying glucose for use as a placental fuel (28). Specific expression of GLUT3 in the labyrinth, which is specialized in nutrient transfer, suggested that GLUT3 may be important for the maternofetal transfer of glucose (28). GLUT3, having a relatively lower Km value (10, 50) compared with that of GLUT1, may confer effective transfer of glucose into the syncytiotrophoblast in the case of hypoglycemia in a similar manner as in neurons and also serve for retention of the sugar in the syncytiotrophoblast as a reservoir. In fact, deposition of glycogen in the syncytiotrophoblast layers was reported by electron microscopy (37, 41). Because detailed examination of the localization of GLUT1 and GLUT3 in the labyrinthine wall would provide evidence to determine the validity of this notion, we carried out high resolution immunofluorescence and immunoelectron microscopic studies. We found that both GLUT3 and GLUT1 were localized at the plasma membrane of the syncytiotrophoblast I facing the maternal blood side, a site of entry into the syncytial layers from the maternal blood side. Both GLUT3 and GLUT1, especially GLUT3 with its higher affinity for glucose, should play an important role for the entry of glucose into the syncytial cell layers. Only GLUT1 was detected at the plasma membrane of syncytiotrophoblast II facing the fetal blood side, the site of exit from the syncytial cell layers to the fetal blood side. Therefore, GLUT3 could not be directly involved in the efflux into the fetal blood side from the syncytiotrophoblast layers, the site of the placental barrier. Instead, GLUT1 should play a prime role for the exit of glucose from the syncytial layers. In addition to GLUT1 and GLUT3, abundant connexin 26 is present between the two syncytiotrophoblast layers connected by gap junctions (21). Taking into account the ultrastructure of the placental labyrinth (35, 40, 41, 42) and the localization of GLUT3, GLUT1 (39), and connexin 26 (21), we suggest that transfer of glucose across the placental barrier occurs as follows: glucose freely passes the cytotrophoblast layer through pores in it. GLUT3 and GLUT1 in the syncytiotrophoblast I are responsible for the uptake of glucose into its cytoplasm. Glucose is then transferred to the cytoplasm of the syncytiotrophoblast II via connexin 26 channels of gap junctions between the two syncytial cell layers. Glucose leaves the syncytiotrophoblast II via GLUT1, and enters the fetal circulation by crossing the endothelial cell through numerous fenestrations. The function of GLUT3 at the plasma membrane of syncytiotrophoblast II facing syncytiotrophoblast I remains to be clarified. It may possibly serve to retrieve glucose that somehow managed to pass the syncytiotrophoblast I, the first barrier cell layer.

In the placentas of diabetic rats, placental GLUT3 messenger RNA and protein increased, whereas those of GLUT1 remained unchanged (29). A similar increase in GLUT3 was also observed in rats with short-term hyperglycemia achieved by hyperglycemic clamps (29). GLUT3 in the rat placenta, therefore, appears to be highly sensitive to the blood glucose level and to play an important role in the alteration of placental function in the diabetic placenta (29). These results are basically in accord with our model of glucose transfer, that GLUT1 localized at the site of entry and exit in the placental barrier may ensure a basal transfer of maternofetal glucose transfer. Asymmetric distribution of GLUT3 in the syncytiotrophoblast layers may suggest asymmetric kinetics of glucose transfer across the placental barrier. Presence of both GLUT1 and GLUT3 at the site of entry into and of GLUT1 at the site of exit from the barrier would confer the retention of glucose in the fetus and would be beneficial to provide a stable milieu for the fetal development. In hyperglycemia, increases in GLUT3 and glycogen were observed (29), suggesting that overflowed glucose can be transferred and stored as glycogen in syncytiotrophoblasts within placenta through GLUT3 facing the maternal side. Upon maternal hypoglycemia, stored placental sugars may be transferred to the fetal blood circulation through GLUT1 facing the fetal side for fetal development, which transfer would prevent a large fluctuation of the glucose level in the fetal blood. Syncytiotrophoblasts therefore could serve not only as a transfer machinery, but also as a reservoir of nutrients. GLUT3, with its high affinity for glucose, localized at the membrane of syncytiotrophoblast I facing the maternal blood sides, may ensure the influx of glucose into syncytiotrophoblast I under the condition of maternal hypoglycemia.

In the ciliary body epithelium, double-epithelial cell layers composed of pigmented and nonpigmented epithelial cells serve as the structural basis for the blood-aqueous barrier (14, 38, 51). GLUT1 is abundant at the plasma membrane of pigmented cells facing blood vessels and of nonpigmented cells facing the aqueous humor (14, 16). Numerous gap junctions composed of connexin 43 (Cx43) connect the double epithelial cell layers (16). In the rat placenta, where the barrier is also made of double cell layers, abundant gap junctions of connexin 26 connect these double cell layers (21). Connexins, connecting these two layers, can serve as nonspecific hydrophilic channels for relatively small molecules such as glucose. We suggested earlier that the combined action of GLUT1, connexin(s), and GLUT1 in series may serve as the machinery for the transfer of glucose across these blood-tissue barriers (16, 21, 39). The asymmetrical presence of GLUT3 in the rat placental barrier could be important for the efficient transfer of glucose while preventing the loss of glucose at the time of maternal hypoglycemia, thereby providing a stable milieu for the developing fetus.


    Acknowledgments
 
We wish to thank Ms. S. Tsukui for secretarial assistance.

Received March 12, 1997.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Bell GI, Kayano T, Buse JB, Burant CF, Takeda J, Lin D, Fukumoto H, Seino S 1990 Molecular biology of mammalian glucose transporters. Diabetes Care 13:198–208[Abstract]
  2. Bell GI, Burant CF, Takeda J, Gould GW 1993 Structure and function of mammalian facilitative sugar transporters. J Biol Chem 268:19161–19164[Free Full Text]
  3. Takata K, Kasahara M, Oka Y, Hirano H 1993 Mammalian sugar transporters: their localization and link to cellular functions. Acta Histochem Cytochem 26:165–178
  4. Silverman M 1991 Structure and function of hexose transporters. Annu Rev Biochem 60:757–794[CrossRef][Medline]
  5. Mueckler M 1994 Facilitative glucose transporters. Eur J Biochem 219:713–725[Medline]
  6. Wright EM 1993 The intestinal Na+/glucose cotransporter. Annu Rev Physiol 55:575–589[CrossRef][Medline]
  7. Harik SI, Kalaria RN, Andersson L, Lundahl P, Perry G 1990 Immunocytochemical localization of the erythroid glucose transporter: abundance in tissues with barrier functions. J Neurosci 10:3862–3872[Abstract]
  8. Thomas HM, Brant AM, Colville CA, Seatter MJ, Gould GW 1992 Tissue-specific expression of facilitative glucose transporters: a rationale. Biochem Soc Trans 20:538–542[Medline]
  9. Baldwin SA 1993 Mammalian passive glucose transporters: members of an ubiquitous family of active and passive transport proteins. Biochim Biophys Acta 1154:17–49[Medline]
  10. Gould GW, Holman GD 1993 The glucose transporter family: structure, function and tissue-specific expression. Biochem J 295:329–341
  11. Takata K, Hirano H, Kasahara M 1997 Transport of glucose across the blood-tissue barriers. Intl Rev Cytol 172:1–53
  12. Kalaria RN, Gravina SA, Schmidley JW, Perry G, Harik SI 1988 The glucose transporter of the human brain and blood-brain barrier. Ann Neurol 24:757–764[CrossRef][Medline]
  13. Harik SI, Kalaria RN, Whitney PM, Andersson L, Lundahl P, Ledbetter SR, Perry G 1990 Glucose transporters are abundant in cells with "occluding" junctions at the blood-eye barriers. Proc Natl Acad Sci USA 87:4261–4264[Abstract/Free Full Text]
  14. Takata K, Kasahara T, Kasahara M, Ezaki O, Hirano H 1991 Ultracytochemical localization of the erythrocyte/HepG2-type glucose transporter (GLUT1) in the ciliary body and iris of the rat eye. Invest Ophthalmol Vis Sci 32:1659–1666[Abstract/Free Full Text]
  15. Takata K, Kasahara T, Kasahara M, Ezaki O, Hirano H 1992 Ultracytochemical localization of the erythrocyte/HepG2-type glucose transporter (GLUT1) in cells of the blood-retinal barrier in the rat. Invest Ophthalmol Vis Sci 33:377–383[Abstract/Free Full Text]
  16. Shin B-C, Suzuki T, Tanaka S, Kuraoka A, Shibata Y, Takata K 1996 Connexin 43 and Glucose transporter GLUT1 in the ciliary body of the rat. Histochem Cell Biol 106:209–214[Medline]
  17. Takata K, Kasahara T, Kasahara M, Ezaki O, Hirano H 1992 Localization of erythrocyte/HepG2-type glucose transporter (GLUT1) in human placental villi. Cell Tissue Res 267:407–412[CrossRef][Medline]
  18. Takata K, Kasahara T, Kasahara M, Hirano H 1993 Glucose transporter GLUT1 in the placental barrier. In: Nakayama T, Makino T (eds) Fourth Lake Shirakaba Placenta Conference. Keiseisha, Tokyo, pp 54–60
  19. Takata K 1994 Structural basis of glucose transport in the placental barrier: role of GLUT1 and the gap junction. Endocrine J 41:S3–S8
  20. Hahn T, Hartmann M, Blaschitz A, Skofitsch G, Graf R, Dohr G, Desoye G 1995 Localization of the high affinity facilitative glucose transporter protein GLUT1 in the placenta of human, marmoset monkey (Callithrix jacchus) and rat at different developmental stages. Cell Tissue Res 280:49–57[Medline]
  21. Shin B-C, Suzuki T, Matsuzaki T, Tanaka S, Kuraoka A, Shibata Y, Takata K 1996 Immunolocalization of GLUT1 and connexin 26 in the rat placenta. Cell Tissue Res 285:83–89[CrossRef][Medline]
  22. Thorens B 1992 Molecular and cellular physiology of GLUT-2, a high-Km facilitated diffusion glucose transporter. Intl Rev Cytol 137A:209–238
  23. Nagamatsu S, Kornhauser JM, Burant CF, Seino S, Mayo KE, Bell GI 1992 Glucose transporter expression in brain. J Biol Chem 267:467–472[Abstract/Free Full Text]
  24. Mantych GJ, James DE, Chung HD, Devaskar SU 1992 Cellular localization and characterization of Glut3 glucose transporter isoform in human brain. Endocrinology 131:1270–1278[Abstract]
  25. Haber RS, Weinstein SP, O’Boyle E, Morgello S 1993 Tissue distribution of the human GLUT3 glucose transporter. Endocrinology 132:2538–2543[Abstract]
  26. Gerhart DZ, Leino RL, Borson ND, Taylor WE, Gronlund KM, McCall AL, Drewes LR 1995 Localization of glucose transporter GLUT3 in brain: comparison of rodent and dog using species-specific carboxyl-terminal antisera. Neuroscience 66:237–246[CrossRef][Medline]
  27. Shepherd PR, Gould GW, Colville CA, McCoid SC, Gibbs EM, Kahn BB 1992 Distribution of GLUT3 glucose transporter protein in human tissues. Biochem Biophys Res Commun 188:149–154[CrossRef][Medline]
  28. Zhou J, Bondy CA 1993 Placental glucose transporter gene expression and metabolism in the rat. J Clin Invest 91:845–852
  29. Boileau P, Mrejen C, Girard J, Hauguel-de Mouzon S 1995 Overexpression of GLUT3 placental glucose transporter in diabetic rats. J Clin Invest 96:309–317
  30. James DE, Strube M, Mueckler M 1989 Molecular cloning and characterization of an insulin-regulatable glucose transporter. Nature 338:83–87[CrossRef][Medline]
  31. Slot JW, Geuze HJ, Gigengack S, James DE, Lienhard GE 1991 Translocation of the glucose transporter GLUT4 in cardiac myocytes of the rat. Proc Natl Acad Sci USA 88:7815–7819[Abstract/Free Full Text]
  32. Slot JW, Geuze HJ, Gigengack S, Lienhard GE, James DE 1991 Immuno-localization of the insulin regulatable glucose transporter in brown adipose tissue of the rat. J Cell Biol 113:123–135[Abstract/Free Full Text]
  33. Birnbaum MJ 1992 The insulin-sensitive glucose transporter. Intl Rev Cytol 137A:239–297
  34. Castellucci M, Kaufmann P 1995 Basic structure of the villous trees. In: Benirschke K, Kaufmann P (eds) Pathology of the human placenta, ed 3. Springer, New York, pp 57–115
  35. Takata K, Fujikura K, Shin B-C 1997 Ultrastructure of the rodent placental labyrinth: a site of barrier and transport. J Reprod Develop 43:13–24[CrossRef]
  36. Jollie WP 1964 Fine structural changes in placental labyrinth of the rat with increasing gestational age. J Ultrastruct Res 10:27–47
  37. Enders AC 1965 A comparative study of the fine structure of the trophoblast in several hemochorial placentas. Am J Anat 116:29–68[CrossRef][Medline]
  38. Takata K, Kasahara T, Kasahara M, Ezaki O, Hirano H 1990 Erythrocyte/HepG2-type glucose transporter is concentrated in cells of blood-tissue barriers. Biochem Biophys Res Commun 173:67–73[CrossRef][Medline]
  39. Takata K, Kasahara T, Kasahara M, Ezaki O, Hirano H 1994 Immunolocalization of glucose transporter GLUT1 in the rat placental barrier: possible role of GLUT1 and the gap junction in the transport of glucose across the placental barrier. Cell Tissue Res 276:411–418[Medline]
  40. Forssmann WG, Metz J, Heinrich D 1975 Gap junctions in the hemotrichorial placenta of the rat. J Ultrastruct Res 53:374–381[CrossRef][Medline]
  41. Metz J, Heinrich D, Forssmann WG 1976 Ultrastructure of the labyrinth in the rat full-term placenta. Anat Embryol 149:123–148[CrossRef][Medline]
  42. Metz J, Heinrich D, Forssmann WG 1976 Gap junctions in hemodichorial and hemotrichorial placentae. Cell Tissue Res 171:305–315[CrossRef][Medline]
  43. Mueckler M, Caruso C, Baldwin SA, Panico M, Blench I, Morris HR, Allard WJ, Lienhard GE, Lodish HF 1985 Sequence and structure of a human glucose transporter. Science 229:941–945[Abstract/Free Full Text]
  44. Kasahara M, Inui K, Takano M, Hori R 1985 Distinction of three types of D-glucose transport systems in animal cells. Biochem Biophys Res Commun 132:490–496[CrossRef][Medline]
  45. Nagamatsu S, Sawa H, Kamada K, Nakamichi Y, Yoshimoto K, Hoshino T 1993 Neuron-specific glucose transporter (NSGT): CNS distribution of GLUT3 rat glucose transporter (RGT3) in rat central neurons. FEBS Lett 334:289–295[CrossRef][Medline]
  46. Van Bueren AM, Moholt-Siebert M, Begley DE, McCall AL 1993 An immunization method for generation of high affinity antisera against glucose transporters useful in immunohistochemistry. Biochem Biophys Res Commun 197:1492–1498[CrossRef][Medline]
  47. Inukai K, Katagiri H, Takata K, Asano T, Anai M, Ishihara H, Nakazaki M, Kikuchi M, Yazaki Y, Oka Y 1995 Characterization of rat GLUT5 and functional analysis of chimeric proteins of GLUT1 glucose transporter and GLUT5 fructose transporter. Endocrinology 136:4850–4857[Abstract]
  48. Sawada H, Esaki M 1994 Use of Nanogold followed by silver enhancement and gold toning for preembedding immunolocalization in osmium-fixed, Epon-embedded tissues. J Electron Microsc 43:361–366[Abstract/Free Full Text]
  49. Murata F, Tsuyama S, Ihida K, Kashio N, Kawano M, Li ZZ 1992 Sulfated glycoconjugates demonstrated in combination with high iron diamine thiocarbohydrazide-silver proteinate and silver acetate physical development. J Electron Microsc 41:14–20[Abstract/Free Full Text]
  50. Gould GW, Thomas HM, Jess TJ, Bell GI 1991 Expression of human glucose transporters in Xenopus oocytes: kinetic characterization and substrate specificities of the erythrocyte, liver, and brain isoforms. Biochemistry 30:5139–5145[CrossRef][Medline]
  51. Raviola G 1977 The structural basis of the blood-ocular barriers. Exp Eye Res [Suppl] 25:27–63



This article has been cited by other articles:


Home page
Chem SensesHome page
A. Ablimit, T. Aoki, T. Matsuzaki, T. Suzuki, H. Hagiwara, S. Takami, and K. Takata
Immunolocalization of Water Channel Aquaporins in the Vomeronasal Organ of the Rat: Expression of AQP4 in Neuronal Sensory Cells
Chem Senses, June 1, 2008; 33(5): 481 - 488.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Ganguly, R. A. McKnight, S. Raychaudhuri, B.-C. Shin, Z. Ma, K. Moley, and S. U. Devaskar
Glucose transporter isoform-3 mutations cause early pregnancy loss and fetal growth restriction
Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1241 - E1255.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Constancia, E. Angiolini, I. Sandovici, P. Smith, R. Smith, G. Kelsey, W. Dean, A. Ferguson-Smith, C. P. Sibley, W. Reik, et al.
Adaptation of nutrient supply to fetal demand in the mouse involves interaction between the Igf2 gene and placental transporter systems
PNAS, December 27, 2005; 102(52): 19219 - 19224.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Pavek, F. Staud, Z. Fendrich, H. Sklenarova, A. Libra, M. Novotna, M. Kopecky, M. Nobilis, and V. Semecky
Examination of the Functional Activity of P-glycoprotein in the Rat Placental Barrier Using Rhodamine 123
J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1239 - 1250.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. Thompson, V.K.M. Han, and K. Yang
Spatial and Temporal Patterns of Expression of 11{beta}-Hydroxysteroid Dehydrogenase Types 1 and 2 Messenger RNA and Glucocorticoid Receptor Protein in the Murine Placenta and Uterus During Late Pregnancy
Biol Reprod, December 1, 2002; 67(6): 1708 - 1718.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
U. G. Das, J. He, R. A. Ehrhardt, W. W. Hay Jr., and S. U. Devaskar
Time-dependent physiological regulation of ovine placental GLUT-3 glucose transporter protein
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2000; 279(6): R2252 - R2261.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
H. Sawada and M. Esaki
A Practical Technique to Postfix Nanogold-immunolabeled Specimens with Osmium and to Embed Them in Epon for Electron Microscopy
J. Histochem. Cytochem., April 1, 2000; 48(4): 493 - 498.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
Y. Kamei, O. Tsutsumi, A. Yamakawa, Y. Oka, Y. Taketani, and J. Imaki
Maternal Epidermal Growth Factor Deficiency Causes Fetal Hypoglycemia and Intrauterine Growth Retardation in Mice: Possible Involvement of Placental Glucose Transporter GLUT3 Expression
Endocrinology, September 1, 1999; 140(9): 4236 - 4243.
[Abstract] [Full Text]


Home page
J. Cell Biol.Home page
H.-D. Gabriel, D. Jung, C. Butzler, A. Temme, O. Traub, E. Winterhager, and K. Willecke
Transplacental Uptake of Glucose Is Decreased in Embryonic Lethal Connexin26-deficient Mice
J. Cell Biol., March 23, 1998; 140(6): 1453 - 1461.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shin, B.-C.
Right arrow Articles by Takata, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shin, B.-C.
Right arrow Articles by Takata, K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals